Skip to main content
logo
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.285
+0.095 (2.98%)
Oct 21, 2026, 4:00 PM EDT - Market closed

Whitehawk Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1871147850313505
Market Cap Growth
49.39%46.66%56.96%-84.17%-37.97%-
Enterprise Value
-3-4916-68132344
Last Close Price
3.292.423.152.0212.8324.15

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-15.962.992.0320.57450.53
PB Ratio
1.020.841.480.471.983.70
P/TBV Ratio
1.020.841.480.471.983.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--0.62-8.66306.99

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.020.010.010.00
Net Debt / Equity Ratio
-1.04-1.07-0.88-1.02-1.08-1.09
Net Debt / EBITDA Ratio
2.211.270.721.502.914.01
Net Debt / FCF Ratio
2.741.490.761.693.416.60
Asset Turnover
-0.070.260.150.090.01
Inventory Turnover
--0.5212.49--
Quick Ratio
17.1610.043.114.339.269.76
Current Ratio
17.3810.263.594.729.569.90
Return on Equity (ROE)
-44.98%-21.82%-80.79%-49.90%-41.06%-177.60%
Return on Assets (ROA)
-28.70%-64.66%-39.96%-28.39%-21.54%-26.21%
Return on Capital Employed (ROCE)
-47.00%-83.90%-121.70%-67.80%-35.60%-26.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-33.42%-18.06%-81.90%-132.75%-19.33%-21.82%
FCF Yield
-37.03%-85.91%-78.71%-128.45%-16.00%-4.45%
Buyback Yield / Dilution
-78.42%-128.96%-0.42%-19.58%-152.27%-250.99%